SANDLER ALAN B. (Chief Development Officer) sold 10.7% of their position (6.31K shares) of REVOLUTION MEDICINES, INC. on the open market
Open‑market sale worth $1.28M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+6K
Price / share
$58.84
Trade value
$353.04K
% of position
Common Stock
Shares
−2.20K
Price / share
$200.82
Trade value
$441.80K
% of position
Common Stock
Shares
−1.61K
Price / share
$201.72
Trade value
$324.57K
% of position
Common Stock
Shares
−1K
Price / share
$202.81
Trade value
$202.81K
% of position
Common Stock
Shares
−1.20K
Price / share
$203.91
Trade value
$244.48K
% of position
Common Stock
Shares
−301.00
Price / share
$204.72
Trade value
$61.62K
% of position
Net shares
−309.00
Net value
-$922.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/29/2026 | M · Option Exercise | +6K | $58.84 | $353.04K | 11.3% | 52.87K | 58.87K |
| Common Stock Direct | 9/29/2026 | S · Sale | −2.20K | $200.82 | $441.80K | 3.7% | 58.87K | 56.67K |
| Common Stock Direct | 9/29/2026 | S · Sale | −1.61K | $201.72 | $324.57K | 2.8% | 56.67K | 55.06K |
| Common Stock Direct | 9/29/2026 | S · Sale | −1K | $202.81 | $202.81K | 1.8% | 55.06K | 54.06K |
| Common Stock Direct | 9/29/2026 | S · Sale | −1.20K | $203.91 | $244.48K | 2.2% | 54.06K | 52.86K |
| Common Stock Direct | 9/29/2026 | S · Sale | −301.00 | $204.72 | $61.62K | 0.6% | 52.86K | 52.56K |
| Total | −309.00 | -$922.25K | ||||||
Stock Option (Right to Buy)
Common Stock
167.30K shares
Shares
−6K
Strike price
58.84
Held after
161.30K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock167.30K shares | 9/29/2026 | M · Option Exercise | −6K | 58.84 | — | 161.30K |